Cigarette Smoking and Clinically Significant Drug Interactions

Abstract

Spanish

French

Objective:

To review clinically significant drug interactions associated with cigarette smoking.

Data Sources:

Data from scientific literature were identified by using a MEDLINE search. Data were extracted, evaluated, and summarized for this review.

Study Selection:

Findings and experiences were selected from clinical, epidemiologic, and pharmacokinetic studies; review articles; case studies; abstracts; letters to the editor; and proceedings.

Data Extraction:

Data from human studies published in English were evaluated. Only interactions deemed clinically significant are included in this review. Conclusions derived from review articles on the subject of smoking and drug interactions also were used.

Data Synthesis:

Cigarette smoking can affect drug therapy via pharmacokinetic and pharmacodynamic mechanisms. Pharmacokinetic drug interactions are presented for theophylline, tacrine, insulin, flecainide, propoxyphene, propranolol, diazepam, and chlordiazepoxide. Pharmacodynamic interactions are described for antihypertensive and antianginal agents, antilipidemics, oral contraceptives, and histamine₂-receptor antagonists.

Conclusions:

Cigarette smoking can reduce the efficacy of certain drugs or make drug therapy more unpredictable. Pharmacokinetic interactions may cause smokers to require a larger dosage of certain drugs through an increase in plasma clearance, a decrease in absorption, an induction of cytochrome P450 enzymes, or a combination of these factors. Pharmacodynamic interactions may increase the risk of adverse events in smokers with cardiovascular or peptic ulcer disease, and in women who smoke and use oral contraceptives. Healthcare professionals should pay special attention to patients with these profiles and should try to prevent cigarette smoking or encourage patients to discontinue this addictive habit.

Get full access to this article

View all access options for this article.

References

Severson

, Snook

, Arrendale

, Chortyk

. Gas chromatographic quantitation of polynuclear aromatic hydrocarbons in tobacco smoke. Anal Chem 1976; 48: 1866–72.

Schumacher

, Green

, Best

, Newell

. Smoke composition. An extensive investigation of the water-soluble portion of cigarette smoke. J Agric Food Chem 1977; 25: 310–20.

Conney

. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G.H.A. Clowes memorial lecture. Cancer Res 1982; 42: 4875–917.

Park

. Induction of the drug-metabolizing enzymes. In: Park

ed. Enzyme induction. New York: Plenum Press, 1975: 207–71.

Guengerich

. Characterization of roles of human cytochrome P-450 enzymes in carcinogen metabolism. Asia Pac J Pharmacol 1990; 5: 327–45.

Dawson

, Vestal

. Smoking and drug metabolism. Pharmacol Ther 1982; 15: 207–21.

Welty

, Pool

, Woolf

, Posvar

, Sedman

The effect of smoking on the pharmacokinetics and metabolism of Cognex in healthy volunteers (abstract). Pharm Res 1993; 10:S334.

Van Schooten

, Jongeneelen

, Hillebrand

MJX

, Van Leeuwen

, Looff

AJA

, Dijkmans

APG

Polycyclic aromatic hydrocarbon–DNA adducts in white blood cell DNA and 1-hydroxypyrene in the urine from aluminum workers: relation with job category and synergistic effect of smoking. Cancer Epidemiol Biomarkers Prev 1995; 4: 69–77.

Kalow

, Tang

. Caffeine as a metabolic probe: exploration of the enzyme-inducing effect of cigarette smoking. Clin Pharmacol Ther 1991; 49: 44–8.

10.

Conney

. Induction of microsomal cytochrome P-450 enzymes: the first Bernard B. Brod lecture at Pennsylvania State University. Life Sci 1986; 39: 2493–518.

11.

Griffin

, D'arcy

, Speirs

. Drug interactions and drug-metabolizing enzymes. In: A manual of adverse drug interactions. London: Butterworth, 1988:32.

12.

Conney

, Welch

, Kuntzman

Effects of pesticides on drug and steroid metabolism. Clin Pharmacol Ther 1967; 8: 2–10.

13.

Conney

. Pharmacological implications of microsomal enzyme induction. Pharmacol Rev 1967; 19: 317–66.

14.

Cigarette smoking among adults—United States, 1993. MMWR Morb Mortal Wkly Rep 1994;43: 925–9.

15.

Cigarette smoking among adults—United States, 1991. MMWR Morb Mortal Wkly Rep 1993;42:230–1.

16.

Giovino

, Schooley

, Zhu

B-P.

Surveillance for selected tobacco-use behaviors—United States, 1900–1994. MMWR Morb Mortal Wkly Rep 1994; 43(SS–3).

17.

Lee

, Gilpin

, Pierce

. Changes in the patterns of initiation of cigarette smoking in the United States: 1950, 1965 and 1980. Cancer Epidemiol Biomarkers Prev 1993;2:593–7.

18.

Behavioral risk factors surveillance, 1991. Monitoring progress toward the nation's year 2000 health objectives. MMWR Morb Mortal Wkly Rep 1993;42:1–30.

19.

Hansten

, Horn

. Drug interactions. Seattle: Applied Therapeutics, 1995.

20.

Madsbad

, McHair

, Christiansen

. Influence of smoking on insulin requirement and metabolic status in diabetes mellitus. Diabetes Care 1980; 3: 41–3.

21.

Klemp

, Staberg

, Madsbad Kolendorf

Smoking reduces insulin absorption from subcutaneous tissue. Br Med J 1982; 284: 237.

22.

Jenne

Decreased theophylline half-life in cigarette smokers. Life Sci 1975; 17: 195.

23.

Hunt

, Jusko

, Yurchak

. Effect of smoking on theophylline disposition. Clin Pharmacol Ther 1976; 19: 546–51.

24.

Powell

, Thiercelin

, Vozeh

, Sansom

, Riegelman

The influence of cigarette smoking and sex on theophylline disposition. Am Rev Respir Dis 1977; 116: 17–23.

25.

Lee

, Benowitz

, Jacob

III Cigarette abstinence, nicotine gum, and theophylline disposition. Ann Intern Med 1987; 106: 553–5.

26.

Pfeifer

, Greenblatt

. Clinical toxicity of theophylline in relation to cigarette smoking. Chest 1978; 73: 455–9.

27.

Welch

, Harrison

, Gommi

. Stimulatory effect of cigarette smoking on the hydroxylation of 3,4-benzopyrene and the N-demethylation of 3-methyl-4-monoethylaminoazobenzene by enzymes in human placenta. Clin Pharmacol Ther 1968; 10: 100–8.

28.

Cantrell

, Warr

, Busbee

, Martin

. Induction of aryl hydrocarbon hydroxylase in human pulmonary alveolar macrophages by cigarette smoking. J Clin Invest 1973; 52: 1881–4.

29.

Vestal

, Wood

AJJ

. Influence of age and smoking on drug kinetics in man. Clin Pharmacokinet 1980; 5: 309–19.

30.

Miller

. Recent developments in the study of the effects of cigarette smoking on clinical pharmacokinetics and clinical pharmacodynamics. Clin Pharmacokinet 1989; 17: 90–108.

31.

Cognex product information. In: Physicians' desk reference. Montvale, NJ: Medical Economics, 1995:1828.

32.

Effect of cigarette smoking on drug actions. In: Hansten

, Horn

eds. Drug interactions. Seattle: Applied Therapeutics, 1993: 103–4.

33.

Roth

, Shick

. Effect of smoking on the cardiovascular system of man. Circulation 1958; 17: 443–59.

34.

Maddock

, Coller

. Peripheral vasoconstriction by tobacco and its relation to thrombo-angitis obliterans. Ann Surg 1933; 98: 70–81.

35.

McGuffey

Smoking and drug metabolism. Am Pharm 1993;NS33:20.

36.

Mathiesen

, Segaard

, Christianses

. Smoking and glycemic control in male insulin-dependent (type I) diabetics. Diabetes Res 1984; 1: 155–7.

37.

Holtzman

, Weeks

, Kvam

, Berry

, Mottonen

, Ekholm

Identification of drug interactions by meta-analysis of premarketing trials: the effect of smoking on the pharmacokinetics and dosage requirements for flecainide acetate. Clin Pharmacol Ther 1989; 46: 1–8.

38.

Conrad

, Ober

. Metabolism of flecainide. Am J Cardiol 1984; 53:41B–51B.

39.

Boston Collaborative Drug Surveillance Program. Clinical depression of the central nervous system due to diazepam and chlordiazepoxide in relation to cigarette smoking and age. N Engl J Med 1973;288: 277.

40.

Jick

Smoking and clinical drug effects. Med Clin North Am 1974; 58: 1143–9.

41.

Miller

. Effects of smoking on drug action. Clin Pharmacol Ther 1977; 22: 749–56.

42.

Murdock

, Robillard

. Use of smokers in bioavailability studies. Clin Pharmacol Ther 1979; 24: 23.

43.

Seltzer

, Friedman

, Seigelaub

. Smoking habits and pain tolerance. Arch Environ Health 1974; 29: 170–2.

44.

Jusko

. Role of tobacco smoking in pharmacokinetics. J Pharmacokinet Biopharmaceut 1978; 6: 7–39.

45.

Frankl

, Soloff

. The hemodynamic effects of propranolol hydrochloride after smoking. Am J Med Sci 1967; 254: 623–8.

46.

Benowitz

. Pharmacological aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988; 319: 1318–30.

47.

Jusko

. Enhanced biotransformation of theophylline in marijuana and tobacco smokers. Clin Pharmacol Ther 1978; 24: 406.

48.

USPDI. Drug information for the health care professional. 15th ed. Rockville, MD: United States Pharmacopeia] Convention, 1995:2570.

49.

Vaughan

. The influence of smoking on the intersubject variation in pentazocine elimination. Br J Clin Pharmacol 1976; 3: 279.

50.

Keeri-Szanto

, Pomeroy

. Atmospheric pollution and pentazocine metabolism. Lancet 1971; 1: 947–9.

51.

Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. Br Med J 1985;291:97–104.

52.

Dollery

, Brennan

. The Medical Research Council hypertension trial. The smoking patient. Am Heart J 1988; 115: 276–80.

53.

Bühler

, Vesanen

, Watters

, Bolli

Impact of smoking on heart attacks, strokes, blood pressure control, drug dose, and quality of life aspects in the International Prospective Primary Prevention Study in Hypertension. Am Heart J 1988; 115: 282–7.

54.

Bolli

, Buhler

, McKenzie

. Smoking, antihypertensive treatment benefit, and comprehensive antihypertensive treatment approach: some thoughts on the results of the International Prospective Primary Prevention Study in Hypertension. J Cardiovasc Pharmacol 1990; 16(suppl 7):S77–80.

55.

The IPPPSH Collaborative Group. Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). J Hypertens 1985;3:379–91.

56.

Linnoila

, George

, Guthrie

, Leventhal

Effect of alcohol consumption and cigarette smoking on antidepressant levels of depressed patients (letter). Am J Psychiatry 1981; 138: 841.

57.

Perel

, Shostak

, Grann

Pharmacodynamics of imipramine and clinical outcome in depressed patients. In: Gottschalk

, Merlis

eds. Pharmacokinetics of psychoactive drugs. New York: Spectrum, 1975.

58.

Cipolle

, Seifert

, Neilan

, Zaske

, Haus

Heparin kinetics: variables related to disposition and dosage (letter). Clin Pharmacol Ther 1981; 29: 387.

59.

Spain

, Bradess

. Sudden death from coronary heart disease. Survival time, frequency of thrombi, and cigarette smoking. Chest 1970; 58: 107–10.

60.

Kannel

, Doyle

, McNamara

. Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation 1975; 51: 606–13.

61.

Hallstrom

, Cobb

, Ray

Smoking as a risk factor for recurrence of sudden cardiac arrest. N Engl J Med 1986; 314: 271–5.

62.

Rosenberg

, Kaufman

, Helmrich

, Miller

, Stolley

, Shapiro

Myocardial infarction and cigarette smoking in women younger than 50 years of age. JAMA 1985; 253: 2965–9.

63.

Kannel

. Update on the role of cigarette smoking in coronary disease. Am Heart J 1981; 101: 319–28.

64.

Wolf

, D'agostino

, Kannel

. Cigarette smoking as a risk factor for stroke. The Framingham study. JAMA 1988; 259: 1025–9.

65.

Abbott

, Yin

, Reed

. Risk of stroke in male cigarette smoking. N Engl J Med 1986; 315: 717–20.

66.

Beta Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 1982;247: 1707–14.

67.

Tango

, Krogsgaard

, Trap-Jensen

, Schlager

Haemodynamic effects of cigarette smoking before and during long-term non-selective and selective beta-adrenergic blockade in patients with arterial hypertension. Acta Med Scand 1985; 693(suppl):111–4.

68.

Kotamaki

, Manninen

, Laustiola

. Enalapril versus atenolol in the treatment of hypertensive smokers. Eur J Clin Pharmacol 1993; 44: 13–7.

69.

Wilhemsen

, Berglund

, Elmfeldt

, Fitzsimons

, Halzgreze

, Hosie

Beta-blockers versus diuretics in hypertensive men—results from the HAPPY trial. J Hypertens 1987; 5: 561–72.

70.

Black

. Smoking and cardiovascular disease. In: Laragh

, Brenner

eds. Hypertension: pathophysiology, diagnosis, and management. New York: Raven Press, 1990: 1917–36.

71.

Nishihara

, Takashima

, Watanabe

, Kondo

An evaluation of efficacy of cigarette smoking cessation in preventing low levels of serum high-density lipoprotein (HDL) cholesterol. Sangyo Igaku 1991; 33: 231–40.

72.

Croft

, Hannaford

. Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraceptive study. Br Med J 1989; 298: 165–8.

73.

Goldbaum

, Kendrick

, Hogelin

, Gentry

. The relative impact of smoking and oral contraceptive use on women in the United States. JAMA 1987; 258: 1339–42.

74.

Petitti

, Wingerd

, Pellegrin

, Ramcharan

Risk of vascular disease in women: smoking, oral contraceptives, noncontraceptive estrogens, and other factors. JAMA 1979; 242: 1150–4.

75.

Petitti

, Wingerd

Use of oral contraceptives, cigarette smoking, and risk of subarachnoid haemmorrhage. Lancet 1978; 2: 234–6.

76.

Vessey

, Lawless

, Yeates

Oral contraceptives and stroke. Findings in a large prospective study. Br Med J 1984; 289: 530–1.

77.

Burns

. Tobacco and health. In: Wyngaarden

, Smith

eds. Cecil's textbook of medicine. Philadelphia: WB Saunders, 1988: 36–40.

78.

Barrett

, Anda

, Escobedo

. Trends in oral contraceptive use and cigarette smoking. Arch Fam Med 1994; 3: 438–43.

79.

Fox

, Jonathan

, Williams

, Selwyn

Interaction between cigarettes and propranolol in treatment of angina pectoria. Br Med J 1980; 1: 91–3.

80.

Hawkins

. Blood carbon monoxide levels as a function of daily cigarette consumption and physical activity. Br J Ind Med 1976; 33: 123–5.

81.

Allred

, Bleecker

, Chaitman

. Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease. N Engl J Med 1989; 321: 1426–32.

82.

Deanfield

, Wright

, Krikler

, Ribeiro

, Fox

Cigarette smoking and the treatment of angina with propranolol, atenolol, and nifedipine. N Engl J Med 1984; 310: 951–4.

83.

Soll

. Duodenal ulcer and drug therapy. In: Sleisenger

, Fordtran

eds. Gastrointestinal disease. 4th ed. Philadelphia: WB Saunders, 1989:843.

84.

Sontag

, Graham

, Belsito

, Weiss

, Farley

, Grunt

Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. N Engl J Med 1984; 311: 689–93.

85.

Lam

, Hui

, Lau

, Branicki

, Lai

, Lok

ASF

. Sucralfate overcomes adverse effect of cigarette smoking on duodenal ulcer healing and prolongs subsequent remission. Gastroenterology 1987; 92: 1193–201.

86.

McCarthy

. Sucralfate. N Engl J Med 1991; 325: 1017–25.

87.

Ferguson

Smoking, drinking, and non-narcotic analgesic habits in an occupational group. Med J Aust 1973; 1: 1271–4.

88.

Chiverton

, Burget

, Hunt

. Smoking does not impair the response to therapy in duodenal ulcer healing (abstract). Gastroenterology 1988; 94:A69.